TrademarkDir
GALLIUM WAVE
LIVE

Serial Number

79347547

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

Jun 23, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GALLIUM WAVE Trademark

Serial Number: 79347547 • Registration: 7362032

GALLIUM WAVE is a trademark filed by Telix Pharmaceuticals Limited on June 23, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

June 23, 2022

Registration Date

April 23, 2024

Published for Opposition

February 6, 2024

Goods & Services

Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use

Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jan 22, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 11, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 17, 2024 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Oct 25, 2024 FICS
FINAL DISPOSITION PROCESSED
Oct 24, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 24, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 23, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 13, 2024 OPNX
NOTIFICATION PROCESSED BY IB
Feb 6, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 6, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 24, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 24, 2024 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 17, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 17, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 2, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 29, 2023 TROA
REFUSAL PROCESSED BY IB
Jun 26, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 6, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 6, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 12, 2023 RFCR
NON-FINAL ACTION WRITTEN
Apr 11, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 6, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 30, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 26, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 25, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 18, 2022 REPR

Related Trademarks

More from this Owner

LUTEON

LUTEON

PTHER-PAN

PTHER-PAN

PTHER-PAN

PTHER-PAN

BIPASS

BIPASS

BIPASS

BIPASS

UROONCRX ONSITE PRECISION RADIOPHARMACY logo

UROONCRX ONSITE PRECISION RADIOPHARMACY